FDA Approves Drug for Chorea Treatment in Huntington’s Disease
November 26, 2011 Category :Health Watch 0
Xenazine (tetrabenazine) has been approved by the United States Food and Drug Administration (US FDA) as the first drug for the treatment of chorea among patients with Huntington’s disease. “Xenazine represents hope for patients and families dealing with this difficult disease,” said Dr. Timothy Cote, director of FDA’s Office of Orphan Products Development. “For the first time, there is a treatment that can help patients with this disease gain some quality of life.”
Related terms:
- chorea diabetes
- chorea huntington drugs usa 2011
- diabetic chorea
- xenazine bad
- parkinsons treatment
- management of chorea in diabetes
- huntington\s disease
- huntingtons chorea FDA approved treatment
- huntington disease
- huntington diabetes
- diabetics with chorea
- diabetic neuropathy and chorea
- 2011 fda approved huntingtons cure
- diabetes chorea treatment
- diabetes chorea
- Chorea worsened be hearing loss
- chorea philippines
- Chorea Huntington approved treatment FDA
- 2012 chorea huntington drug development